These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 5398002)

  • 21. [The effect of HGF on graft-versus-host disease and graft-versus-leukemia after allogeneic bone marrow transplantation in acute lymphoblastic leukemia mice].
    Xia YJ; Gao QP; Wan CC; Cheng FJ; Liu ZX; Guo RC
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jul; 26(7):404-7. PubMed ID: 16251021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of paternal veto cells in preventing graft-versus-host disease after HLA-haploidentical stem cell transplantation in mice].
    Wang SB; Guo KY; Hu DM
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):79-81. PubMed ID: 18227034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy of established graft-versus-host disease in mice.
    Glucksberg H; Fefer A
    Transplantation; 1972 Mar; 13(3):300-5. PubMed ID: 5021439
    [No Abstract]   [Full Text] [Related]  

  • 24. Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation.
    Saad AG; Alyea EP; Wen PY; Degirolami U; Kesari S
    J Clin Oncol; 2009 Oct; 27(30):e147-9. PubMed ID: 19667266
    [No Abstract]   [Full Text] [Related]  

  • 25. Possibility of three distinct and separable components to fatal graft-vs-host reaction.
    Okunewick JP; Meredith RF; Raikow RB; Buffo MJ; Jones DL
    Exp Hematol; 1982 Mar; 10(3):277-91. PubMed ID: 7040093
    [No Abstract]   [Full Text] [Related]  

  • 26. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
    Lin Q; Dong M; Wang QM; Wen JY; Wu XY
    Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of KRN7000 on induced graft-vs-host disease.
    Morecki S; Panigrahi S; Pizov G; Yacovlev E; Gelfand Y; Eizik O; Slavin S
    Exp Hematol; 2004 Jul; 32(7):630-7. PubMed ID: 15246159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?
    Hirshfeld E; Weiss L; Kasir J; Zeira M; Slavin S; Shapira MY
    Bone Marrow Transplant; 2006 Sep; 38(5):359-64. PubMed ID: 16862165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors.
    Ellison CA; Fischer JM; HayGlass KT; Gartner JG
    J Immunol; 1998 Jul; 161(2):631-40. PubMed ID: 9670937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease.
    Ohashi M; Kobayashi A; Hara H; Miura Y; Yoshida K; Kushida M; Ikarashi Y; Mandai M; Kitajima M; Yoshida T; Aoki K
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2208-15. PubMed ID: 16609036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation protocols determine acute graft-versus-host disease incidence after allogeneic bone marrow transplantation in murine models.
    Schwarte S; Bremer M; Fruehauf J; Sorge Y; Skubich S; Hoffmann MW
    Int J Radiat Biol; 2007 Sep; 83(9):625-36. PubMed ID: 17654104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo T-cell receptor ligation facilitates alloengraftment and prevents lethal graft-versus-host disease (GVHD) in mice.
    Blazar BR; Taylor PA; Vallera DA
    Bone Marrow Transplant; 1993; 12 Suppl 3():S38-40. PubMed ID: 8124256
    [No Abstract]   [Full Text] [Related]  

  • 34. Expression of TNFalpha by CD3+ and F4/80+ cells following irradiation preconditioning and allogeneic spleen cell transplantation.
    Brown S; Konopa J; Zhou D; Thompson J
    Bone Marrow Transplant; 2004 Feb; 33(4):359-65. PubMed ID: 14676780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
    Du B; Li DP; Xu KL; Pan XY
    Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow transplantation in the cat.
    Haskins ME; Wortman JA; Wilson S; Wolfe JH
    Transplantation; 1984 Jun; 37(6):634-6. PubMed ID: 6375021
    [No Abstract]   [Full Text] [Related]  

  • 37. Alveolar hemorrhage and acute graft-versus-host disease.
    Ratajczak P; Desveaux A; Socié G; Janin A
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1244-5. PubMed ID: 17889362
    [No Abstract]   [Full Text] [Related]  

  • 38. FK506 inhibits severe graft-versus-host disease without mediating the involvement of perforin and granzyme B.
    Tao HR
    Hokkaido Igaku Zasshi; 1998 May; 73(3):227-37. PubMed ID: 9719949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting T cells for GVHD therapy.
    Vallera DA
    Semin Cancer Biol; 1996 Apr; 7(2):57-64. PubMed ID: 8740560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of TJU103 in prevention of graft-versus-host disease after allogeneic stem cell transplantation in mice].
    Wang SB; Guo KY; Hu DM; Yin B
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):810-3. PubMed ID: 16793606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.